FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
ZAVZPRET
zavegepant
Peak
Pfizer
NASAL · SPRAY, METERED
2023
NDA0/100
ZECUITY
sumatriptan succinate
Peak
Teva
IONTOPHORESIS · SYSTEM
2013
NDA0/100
ZEGALOGUE
dasiglucagon
Peak
SUBCUTANEOUS · SOLUTION
2021
NDA0/100
ZEGALOGUE (AUTOINJECTOR)
dasiglucagon
Peak
SUBCUTANEOUS · SOLUTION
2021
NDA0/100
ZEJULA
niraparib tosylate
Peak
GSK
ORAL · CAPSULE
2017
NDA0/100
ZELBORAF
vemurafenib
Peak
Roche
ORAL · TABLET
2011
SMNDA0/100
ZEMBRACE SYMTOUCH
sumatriptan succinate
Peak
SUBCUTANEOUS · SOLUTION
2016
NDA0/100
ZEMDRI
plazomicin
Peak
Cipla
INTRAVENOUS · SOLUTION
2018
NDA0/100
ZEPATIER
elbasvir and grazoprevir
Peak
Merck & Co.
ORAL · TABLET
2016
SMNDA0/100
ZEPOSIA
ozanimod hydrochloride
Peak
Bristol Myers Squibb
ORAL · CAPSULE
2020
NDA0/100
ZEPZELCA
lurbinectedin
Peak
Jazz Pharmaceuticals
INTRAVENOUS · POWDER
2020
NDA0/100
ZERBAXA
ceftolozane and tazobactam
Peak
INTRAVENOUS · POWDER
2014
NDA0/100
ZERVIATE
cetirizine
Peak
OPHTHALMIC · SOLUTION/DROPS
2017
NDA0/100
ZILRETTA
triamcinolone acetonide extended-release injectable suspension
Peak
INTRA-ARTICULAR · FOR SUSPENSION, EXTENDED RELEASE
2017
NDA0/100
ZIMHI
naloxone hydrochloride
Peak
INTRAMUSCULAR, SUBCUTANEOUS · SOLUTION
2021
NDA0/100
ZINGO
lidocaine hydrochloride monohydrate
Peak
R-Pharm US
INTRADERMAL · SYSTEM
2007
NDA0/100
ZOHYDRO ER
hydrocodone bitartrate
Peak
ORAL · CAPSULE, EXTENDED RELEASE
2013
NDA0/100
ZOLPIMIST
zolpidem tartrate
Peak
Aytu BioPharma
ORAL · SPRAY, METERED
2008
NDA0/100
ZONISADE
zonisamide
Peak
R-Pharm US
ORAL · SUSPENSION
2022
NDA0/100
ZORYVE
roflumilast
Peak
Arcutis Biotherapeutics
TOPICAL · CREAM
2022
NDA0/100
ZTALMY
ganaxolone
Peak
Marinus Pharmaceuticals
ORAL · SUSPENSION
2022
NDA0/100
ZTLIDO
lidocaine
Peak
TOPICAL · PATCH
2018
NDA0/100
ZUBSOLV
buprenorphine hydrochloride and naloxone hydrochloride
Peak
Bridge Therapeutics
SUBLINGUAL · TABLET
2013
NDA0/100
ZULRESSO
brexanolone
Peak
Sage Therapeutics
INTRAVENOUS · SOLUTION
2019
NDA0/100